Der Einfluss verschiedener Volumenersatzmittel und kontinuierlicher venovenöser Hämofiltration (CVVH) im gesunden Schweinemodell auf die klinische Chemie und die Histopathologie der Leber

Autor: Brunk, Sabrina

Die Behandlung kritisch kranker Patienten stellt die Medizin vor gro��e Herausforderungen. Die h��ufig multimorbiden Patienten werden einer gro��en Bandbreite von Therapiemodulen unterzogen, die neben An��sthesie, Medikation und paren

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c67112f738136db696c560f7d433ca2
https://refubium.fu-berlin.de/handle/fub188/33966

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Loss of murine Gfi1 causes neutropenia and induces osteoporosis depending on the pathogen load and systemic inflammation.

Autor: Geissler S; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Julius Wolff Institute, Berlin, Germany., Textor M; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Julius Wolff Institute, Berlin, Germany., Stumpp S; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute for Medical Genetics and Human Genetics, Berlin, Germany., Seitz S; University Medical Center Hamburg-Eppendorf, Department of Orthopaedics, Hamburg, Germany., Lekaj A; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute for Medical Genetics and Human Genetics, Berlin, Germany., Brunk S; Institut für Tierpathologie, Berlin, Germany., Klaassen S; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Experimental and Clinical Research Center (ECRC), a joint cooperation between the Charité Medical Faculty and the Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Pediatric Cardiology, Berlin, Germany., Schinke T; University Medical Center Hamburg-Eppendorf, Department of Osteology and Biomechanics, Hamburg, Germany., Klein C; Dr. von Hauner Children's Hospital, Ludwig Maximilians University, Department of Pediatrics, Munich, Germany., Mundlos S; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute for Medical Genetics and Human Genetics, Berlin, Germany.; Max Planck Institute for Molecular Genetics, FG Development & Disease, Berlin, Germany., Kornak U; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute for Medical Genetics and Human Genetics, Berlin, Germany.; Max Planck Institute for Molecular Genetics, FG Development & Disease, Berlin, Germany., Kühnisch J; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute for Medical Genetics and Human Genetics, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Experimental and Clinical Research Center (ECRC), a joint cooperation between the Charité Medical Faculty and the Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.; Max Planck Institute for Molecular Genetics, FG Development & Disease, Berlin, Germany.

Publikováno v: PloS one [PLoS One] 2018 Jun 07; Vol. 13 (6), pp. e0198510. Date of Electronic Publication: 2018 Jun 07 (Print Publication: 2018).